Tessa Buckle1, Albertus W Hensbergen2, Danny M van Willigen2, Frank Bosse3, Kevin Bauwens4, Rob C M Pelger5, Fijs W B van Leeuwen6,7. 1. Interventional Molecular Imaging Laboratory, Department of Radiology, Leiden University Medical Center, Albinusdreef 2, 2300 RC, Leiden, The Netherlands. t.buckle@lumc.nl. 2. Interventional Molecular Imaging Laboratory, Department of Radiology, Leiden University Medical Center, Albinusdreef 2, 2300 RC, Leiden, The Netherlands. 3. Neurologische Klinik, Heinrich-Heine University Dusseldorf, Düsseldorf, Germany. 4. ORSI Academy, Melle, Belgium. 5. Department of Urology, Leiden University Medical Center, Leiden, The Netherlands. 6. Interventional Molecular Imaging Laboratory, Department of Radiology, Leiden University Medical Center, Albinusdreef 2, 2300 RC, Leiden, The Netherlands. f.w.b.van_leeuwen@lumc.nl. 7. ORSI Academy, Melle, Belgium. f.w.b.van_leeuwen@lumc.nl.
Abstract
BACKGROUND: Surgically induced nerve damage is a common but debilitating side effect in oncological surgery. With the aim to use fluorescence guidance to enable nerve-sparing interventions in future surgery, a fluorescent tracer was developed that specifically targets myelin protein zero (P0). RESULTS: Truncated homotypic P0 protein-based peptide sequences were C-terminally functionalized with the far-red cyanine dye Cy5. The lead compound Cy5-P0101-125 was selected after initial solubility, (photo)physical and in vitro evaluation (including P0-blocking experiments). Cy5-P0101-125 (KD = 105 ± 17 nM) allowed in vitro and ex vivo P0-related staining. Furthermore, Cy5-P0101-125 enabled in vivo fluorescence imaging of the Sciatic nerve in mice after local intravenous (i.v.) administration and showed compatibility with a clinical fluorescence laparoscope during evaluation in a porcine model undergoing robot-assisted surgery. Biodistribution data revealed that i.v. administered [111In]In-DTPA-P0101-125 does not enter the central nervous system (CNS). CONCLUSION: P0101-125 has proven to be a potent nerve-specific agent that is able to target P0/myelin under in vitro, ex vivo, and in vivo conditions without posing a threat for CNS-related toxicity.
BACKGROUND: Surgically induced nerve damage is a common but debilitating side effect in oncological surgery. With the aim to use fluorescence guidance to enable nerve-sparing interventions in future surgery, a fluorescent tracer was developed that specifically targets myelin protein zero (P0). RESULTS: Truncated homotypic P0 protein-based peptide sequences were C-terminally functionalized with the far-red cyanine dye Cy5. The lead compound Cy5-P0101-125 was selected after initial solubility, (photo)physical and in vitro evaluation (including P0-blocking experiments). Cy5-P0101-125 (KD = 105 ± 17 nM) allowed in vitro and ex vivo P0-related staining. Furthermore, Cy5-P0101-125 enabled in vivo fluorescence imaging of the Sciatic nerve in mice after local intravenous (i.v.) administration and showed compatibility with a clinical fluorescence laparoscope during evaluation in a porcine model undergoing robot-assisted surgery. Biodistribution data revealed that i.v. administered [111In]In-DTPA-P0101-125 does not enter the central nervous system (CNS). CONCLUSION:P0101-125 has proven to be a potent nerve-specific agent that is able to target P0/myelin under in vitro, ex vivo, and in vivo conditions without posing a threat for CNS-related toxicity.
Entities:
Keywords:
Fluorescence-guided surgery; Myelin protein zero; Nerve imaging; Targeted imaging
Authors: Matthias N Van Oosterom; Daphne D D Rietbergen; Mick M Welling; Henk G Van Der Poel; Tobias Maurer; Fijs W B Van Leeuwen Journal: Expert Rev Med Devices Date: 2019-07-26 Impact factor: 3.166
Authors: R Autorino; F Porpiglia; P Dasgupta; J Rassweiler; J W Catto; L J Hampton; E Lima; V Mirone; I H Derweesh; F M J Debruyne Journal: Eur J Surg Oncol Date: 2017-02-20 Impact factor: 4.424
Authors: R A Valdés Olmos; D D Rietbergen; S Vidal-Sicart; G Manca; F Giammarile; G Mariani Journal: Q J Nucl Med Mol Imaging Date: 2014-06 Impact factor: 2.346